Elevation of plasma homocysteine in natural menopause cannot be explained by a lack of vitamin coenzyme availability: Relevance to the risk of cardiovascular disease

Journal of Nutrition, Health and Aging

Volumn 9, Issue 1, 2005, Pages 59-64

  Masse, P G ^a   Dosy, J ^a   Cole, D E C ^b   Evrovski, J ^b   Mahuren, J D ^c   Coburn, Stephen P ^c,d  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Fort Wayne State Developmental Center   (United States)

^d INDIANA UNIVERSITY PURDUE UNIVERSITY FORT WAYNE   (United States)

Author keywords

Cardiovascular disease; Folate; Homocysteine; Menopause; Vitamin B12; Vitamin B6

Indexed keywords

CYANOCOBALAMIN; ESTROGEN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PYRIDOXINE;

ADULT; ANTHROPOMETRY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DIET; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; LIPID METABOLISM; MENOPAUSE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; NUTRITIONAL STATUS; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL;

EID: 14744290085     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Boushey, C.J., Beresford, S.A., Omenn, G.S., Motulsky, A.G., A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes, J.Am.Med.Assoc., 1995, 274: 1049-1057.
2. Nygard, O., Nordrehaug, J.E., Refsum, H., Ueland, P.M., Farstad, M., Vollset, S.E., Plasma homocysteine levels and mortality in patients with coronary artery disease, N.Engl.J.Med., 1997, 337: 230-236.
3. Refsum, H., Ueland, P., Nygård, O., Vollset, S.E., Homocysteine and cardiovascular disease, Annu.Rev.Med., 1998, 49: 31-62.
4. Selhub, J., Jacques, P.F., Bostom, A.G. et al., Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis, N.Engl.J.Med., 1995, 332: 286-291.
5. Rees, M.M., Rodgers, G.M., Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis, Thromb.Res., 1993, 71: 337-359.
6. Malinow, M.R., Nieto, F.J., Szklo, M., Chambless, L.E., Bond, G., Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study, Circulation, 1993, 87: 1107-1113.
7. Malinow, M.R., Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review, Clin.Chem., 1995, 41: 173-176.
8. Brattström, L.E., Hultberg, B.L., Hardebo, J.E., Folic acid responsive postmenopausal homocysteinemia, Metabolism, 1985, 34: 1073-1077.
9. Harker, L.A., Harlan, J.M., Ross, R., Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons, Circ.Res., 1983, 53: 731-739.
10. Boers, G.H., Smals, A.G., Trijbels, F.J., Leermakers, A.I., Kloppenborg, P.W., Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years, J.Clin.Invest., 1983, 72: 1971-1976.
11. Wilcken, D.E., Gupta, V.J., Cysteine-homocysteine mixed disulphide: differing plasma concentrations in normal men and women, Clin.Sci.(Lond), 1979, 57: 211-215.
12. Andersson, A., Brattstrom, L., Israelsson, B., Isaksson, A., Hamfelt, A., Hultberg, B., Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status, Eur.J.Clin.Invest, 1992, 22: 79-87.
13. Andersson, A., Hultberg, B., Brattstrom, L., Isaksson, A., Decreased serum homocysteine in pregnancy, Eur.J.Clin.Chem.Clin.Biochem., 1992, 30: 377-379.
14. Hak, A.E., Polderman, K.H., Westendorp, I.C. et al., Increased plasma homocysteine after menopause, Atherosclerosis, 2000, 149: 163-168.
15. Mudd, S.H., Levy, H.L., Kraus, J.P., Disorders of transsulfuration. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. eds., The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, 2001, 2007-2056
16. Blom, H.J., Boers, G.H., van den Elzen, J.P., van Roessel, J.J., Trijbels, J.M., Tangerman, A., Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease, Eur.J.Clin.Invest, 1988, 18: 633-638.
17. Mudd, S.H., Poole, J.R., Labile methyl balances for normal humans on various dietary regimens, Metabolism, 1975, 24: 721-735.
18. Kang, S.S., Wong, P.W., Zhou, J.M., Cook, H.Y., Total homocyst(e)ine in plasma and amniotic fluid of pregnant women, Metabolism, 1986, 35: 889-891.
19. Steegers-Theunissen, R.P.M., Boers, G.H.J., Steegers, E.A.P., Trijbels, J.M.F., Thomas, C.M.G., Eskes, T.K.A.B., Effects of sub50 oral contraceptives on homocysteine metabolism: a preliminary study, Contraception, 1992, 45: 129-139.
20. Giltay, E.J., Hoogeveen, E.K., Elbers, J.M., Gooren, L.J., Asscheman, H., Stehouwer, C.D., Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females, J.Clin.Endocrinol.Metab, 1998, 83: 550-553.
21. Brattström, L., Israelsson, B., Olsson, A., Andersson, A., Hultberg, B., Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma, Scand.J.Clin.Lab Invest, 1992, 52: 283-287.
22. Berger, P.B., Herrmann, R.R., Dumesic, D.A., The effect of estrogen replacement therapy on total plasma homocysteine in healthy postmenopausal women, Mayo Clin.Proc., 2000, 75: 18-23.
23. Bray, G.A., The syndrome of obesity: an endocrine approach. In: Degroot, L.J. ed., Endocrinology. Saunders, Philadelphia, 1995, 2624-2662
24. Lee, R.C., Wang, Z.M., Heo, M., Ross, R., Jannssen, I., Heymsfield, S.B., Total body skeletal muscle mass: development and cross-validation of anthropometric prediction models, Am.J.Clin.Nutr., 2000, 72: 796-803.
25. Health and Welfare Canada, Nutrition recommendations: The report of the Scientific Committee, 1990
26. Tietz, N.W., Clinical Guide to Laboratory Tests. W.B. Saunders, Philadelphia, 1990
27. Mahuren, J.D., Coburn, S.P., B-6 vitamers: cation exchange HPLC, J.Nutr.Biochem., 1990, 1: 659-663.
28. Evrovski, J., Callaghan, M., Cole, D.E., Determination of homocysteine by HPLC with pulsed integrated amperometry, Clin.Chem., 1995, 41: 757-758.
29. Vandeberg, P.J., Johnson, D.C., Pulsed electrochemical detection of cysteine, methionine, and glutathione at gold electrodes following their separation by liquid chromatography, Anal.Chem., 1993, 65: 2713-2718.
30. Snedecor, G.W., Cochran, W.G., Statistical Methods. Iowa State University Press, Ames, IA, 1989
31. Ueland, P.M., Refsum, H., Stabler, S.P., Malinow, M.R., Andersson, A., Allen, R.H., Total homocysteine in plasma or serum: methods and clinical applications, Clin.Chem., 1993, 39: 1764-1779.
32. Mansoor, M.A., Ueland, P.M., Aarsland, A., Svardal, A.M., Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria, Metabolism, 1993, 42: 1481-1485.
33. Lumeng, L., Brashear, R.E., Li, T.K., Pyridoxal 5′-phosphate in plasma: source, protein-binding, and cellular transport, J.Lab.Clin.Med., 1974, 84: 334-343.
34. Wouters, M.G., Moorrees, M.T., van der Mooren, M.J. et al., Plasma homocysteine and menopausal status, Eur.J.Clin.Invest, 1995, 25: 801-805.
35. Kang, S.S., Wong, P.W., Cook, H.Y., Norusis, M., Messer, J.V., Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease, J.Clin.Invest., 1986, 77: 1482-1486.
36. Hamfelt, A., Soderhjelm, L., Vitamin B-6 and aging. In: Leklem, J.E., Reynolds, R.D. eds., Clinical and Physiological Applications of Vitamin B-6. Alan R. Liss, Inc., New York, 1988, 95-107
37. Verhoef, P., Meleady, R., Daly, L.E., Graham, I.M., Robinson, K., Boers, G.H., Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group, Eur.Heart J., 1999, 20: 1234-1244.
38. Massé, P.G., Vuilleumier, J.P., Weiser, H., Pyridoxine status as assessed by the concentration of B-6 aldehyde vitamers, Internat.J.Vit.Nutr.Res. , 1989, 59: 344-352.
39. Coburn, S.P., Mahuren, J.D., Jain, M., Zubovic, Y., Wortsman, J., Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate, J.Clin.Endocrinol.Metab., 1998, 83: 3951-3957.
40. Prince, R.L., Dick, I., Devine, A., Price, R.I., Gutteridge, D.H.; Kerr, D.; Criddle, A.; Garcia-Webb, P.; St John, A., The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90, J.Bone Miner.Res., 1995, 10: 835-842.
41. Ray, J.G., Cole, D.E., Boss, S.C., An Ontario-wide study of vitamin B12, serum folate, and red cell folate levels in relation to plasma homocysteine: is a preventable public health issue on the rise?, Clin.Biochem., 2000, 33: 337-343.
42. Rosenblatt, D.S., Inherited disorders of folate transport and metabolism. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. eds., The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, New York, 1995, 3111-3128
43. Majors, A., Ehrhart, L.A., Pezacka, E.H., Homocysteine as a risk factor for vascular disease - Enhanced collagen production and accumulation by smooth muscle cells, Arterioscler.Thromb.Vasc.Biol., 1997, 17: 2074-2081.